Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03063905 · ClinicalTrials.gov registry record
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
A clinical trial, sponsored by Georgetown University.
- Terminated
- Registry status
- 15
- Enrollment target
NCT03063905 is a clinical trial that was terminated before completion, run by Georgetown University. The registered enrollment target is 15 participants.
The verdict
NCT03063905 was terminated before completion, sponsored by Georgetown University.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
Evidence to support the effectiveness of ongoing opioid therapy for the treatment of chronic non-malignant pain is lacking. In fact, data suggest that patient outcomes improve when tapered off opioid analgesics. To better understand the role opioid therapy plays in the experience of pain, we will study measured pain sensitivity in opioid dependent patients over the course of and 3 months following a standardized opioid taper. By isolating the effect of opioid taper in patients without pain, preliminary evidence of effect size can be used to guide clinicians treating patients with chronic pain.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-01 |
| Est. Completion | 2018-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03063905
The ClinicalTrials.gov registry entry for NCT03063905 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT03063905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03063905 about?
NCT03063905 is a clinical study titled "The Effects of Opioid Taper on Opioid-Induced Hyperalgesia". Evidence to support the effectiveness of ongoing opioid therapy for the treatment of chronic non-malignant pain is lacking. In fact, data suggest that patient outcomes improve when tapered off opioid analgesics. To better understand the role opioid therapy plays in the experience of pain, we will st...
What is the current status of trial NCT03063905?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2017-01. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT03063905?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT03063905?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.